ACE2 and COVID-19: Given the high level of angiotensin-converting enzyme-2 (ACE2) expression in the pancreatic islets and prior experiences with new-onset diabetes in SARS-CoV-1 infection, there is a substantial concern regarding the relationship between hyperglycemia and COVID-19 [4].